TACR1 and neoplasm: In the context of cancer, SP binding to NK1R activates downstream signaling cascades including PI3K/Akt/NF-κB pathways that promote tumor cell proliferation, migration, invasion, and angiogenesis while inhibiting apoptosis [78,79].